Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-03

Clinical Trial Update: A Pilot Study of Nocturnal Hypoglycemia Prevention in Type 1 Diabetes Using the Vigilant Diabetes Management Companion [NA]

View source ↗

Summary

The clinical trial update reports that a pilot study evaluating the Vigilant Diabetes Management Companion for nocturnal hypoglycemia prevention in people with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vigilant Diabetes Management Companion

Snippet

Sponsor: InSpark Technologies, Inc. | Conditions: Hypoglycemia, Diabetes Mellitus, Type 1 | NA | Status: TERMINATED